• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C

    2013-07-03 09:20:14

    Gdansk, Poland

    Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C

    Katarzyna Sikorska, Piotr Stalke, Tomasz Romanowski, Robert Rzepko and Krzysztof Piotr Bielawski

    Gdansk, Poland

    BACKGROUND:Liver steatosis and iron overload, which are frequently observed in chronic hepatitis C (CHC), may contribute to the progression of liver injury. This study aimed to evaluate the correlation between liver steatosis and iron overload in Polish patients with CHC compared to nonalcoholic fatty liver disease (NAFLD) andHFE-hereditary hemochromatosis (HH) patients.

    METHODS:A total of 191 CHC patients were compared with 67 NAFLD and 21 HH patients. Liver function tests, serum markers of iron metabolism, cholesterol and triglycerides were assayed. The inflammatory activity, fibrosis, iron deposits and steatosis stages were assessed in liver specimens.HFEgene polymorphisms were investigated by PCR-RFLP.

    RESULTS:Liver steatosis was associated with obesity and diabetes mellitus. This disease was confirmed in 76/174 (44%) CHC patients, most of whom were infected with genotype 1. The average grade of steatosis was higher in NAFLD patients. CHC patients had significantly higher iron concentrations and transferrin saturations than NAFLD patients. Compared with CHC patients, HH patients had higher values of serum iron parameters and more intensive hepatocyte iron deposits without differences in the prevalence and intensity of liver steatosis. In the CHC group, lipids accumulation in hepatocytes was significantly associated with the presence of serummarkers of iron overload. No correlation between theHFEgene polymorphism and liver steatosis in CHC patients was found.

    CONCLUSIONS:Liver steatosis was diagnosed in nearly half of CHC patients, most of whom were infected with genotype 1. The intensity of steatosis was lower in CHC patients than that in NAFLD patients because of a less frequent diagnosis of metabolic syndrome. Only in CHC patients were biochemical markers of iron accumulation positively correlated with liver steatosis; these findings were independent ofHFEgene mutations.

    (Hepatobiliary Pancreat Dis Int 2013;12:377-384)

    hepatitis C virus;iron overload; fatty liver; hemochromatosis; metabolic syndrome X

    Introduction

    Chronic HCV infection affects approximately 3% of the worldwide population and causes essential health problems due to difficulties in antiviral treatment and two serious consequences of chronic infection: liver cirrhosis and hepatocellular carcinoma.[1]Additionally, attempts to eradicate the virus with new directly acting antivirals may be ineffective as a result of enhanced side effects and drug resistance.[2]Liver steatosis and iron overload are observed in chronic hepatitis C (CHC) patients, likely as a result of host and viral factors, and may play an important role as cofactors of disease progression and hepatocellular carcinoma development.[3-5]

    Fatty liver in CHC may be diagnosed as a comorbid disease entity, independent on HCV infection, associated with obvious host features of the coexisting metabolic syndrome (obesity, diabetes mellitus).[6]However, HCV itself may act as a strong inducerof complex syndrome of lipid and carbohydrate metabolism disorders. Experimental studies[7-11]have suggested that lipids accumulation in hepatocytes is a direct consequence of viral cytopathogenic effects. It was demonstrated that HCV core proteins may induce hepatocyte fat accumulation through at least the following mechanisms: (i) the activation of the proteasome activator 28γ (PA28γ) with the upregulation of sterol regulatory element binding protein 1 (SREBP-1) involved in liver fatty acid synthesis,[7]and (ii) the inhibition of microsomal transfer protein activity and very low-density lipoprotein secretion.[8]This model of virus-induced steatosis was reported to be particularly associated with HCV genotype 3 and viral load.[9-11]Moreover, insulin resistance and type 2 diabetes mellitus were confirmed to occur more frequently in CHC patients compared with healthy individuals.[12-14]A model of genotype-specific interference of HCV proteins with intracellular insulin signaling was proposed to explain this observation.[15-17]

    Pathogenesis of liver iron overload observed in CHC is complicated. Very active process of necroinflammation may be followed by iron accumulation in liver tissue, especially in Kupffer cells. On the other hand, experimental studies[18,19]provided evidence on the impact of HCV on the dysregulation of iron homeostasis. It was suggested that iron overload in CHC may depend on the HCV-induced down-regulation of hepcidin expression through the reduced DNA binding activity of transcription factor C/EBPα, which results from oxidative stress in HCV infection.[18,19]However, the possible impact of host genetic factors can not be denied, especially mutations in theHFEgene and their potential causation of iron overload.[20,21]Iron hepatotoxicity is generally associated with oxidative stress. Products of oxidative stress and focal inflammatory reactions activate liver macrophages and profibrogenic cytokine release. The activation of hepatic stellate cells and myofibroblasts constitutes iron-induced liver injury and fibrogenesis.[22-24]The role of iron depletion therapy and its influence on the severity of CHC has been discussed, especially in non-responders to antiviral therapy.[25,26]

    Liver steatosis and iron overload are important players in the pathogenesis of CHC, but the molecular mechanisms of their possibly reciprocal interactions and mutual influence on prognosis are still under investigation. Recently, on the basis of experiments with mice expressing HCV polyprotein, the iron-induced reactive oxygen species (ROS)-activation of the unfolded protein response has been recognized as one of the possible mechanisms of HCV-related liver steatosis.[27]This study was undertaken to investigate a possible correlation between liver steatosis and disturbances of iron homeostasis in Polish CHC patients compared with patients with non-alcoholic fatty liver disease (NAFLD) andHFE-hereditary hemochromatosis (HH).

    Methods

    One hundred ninety-one consecutive CHC patients who had been subjected to antiviral treatment in the Department of Infectious Diseases-Liver Unit, Medical University of Gdansk, were included in this study. The patients were compared with 67 consecutive NAFLD and 21 HH patients recruited in the same department. Patients using drugs or abusing alcohol (daily intake>25 g) were excluded from the study. The study protocol conformed to the ethical guidelines of theHelsinki Declarationand was approved by the Local Independent Bioethics Committee at the Medical University of Gdansk (NKEB 270/2010). Informed consent for participation in this study was obtained from all enrolled subjects.

    Diagnosis of liver damage

    The results of blood morphology and some biochemical serum tests are presented in Table 1. Chronic HBV and HCV infections were detected by ELISA (HBsAg and anti-HCV, respectively) and confirmed by PCR assays of serum samples.[28]HCV genotyping was carried out by RT-PCR LINEAR ARRAY HCV (Roche), and HCV viral load was measured by Roche Taqman according to the manufacturer's instructions. HCV genotyping was performed in 114 patients who were qualified for treatment with pegylated interferon and ribavirin. Other patients included in the study were recruited during qualification for treatment with classical interferon and ribavirin, and HCV genotyping was not carried out in these patients. In the present group of patients with CHC, 96 patients (84%) were infected with genotype 1, 14 (12%) with genotype 3, and 4 (4%) with genotype 4.

    The diagnosis of NAFLD was based on liver ultrasound examination, increased blood fatty acids concentration and the exclusion of other liver damaging factors. Liver steatosis was confirmed by liver biopsy. Hyperlipidemia was diagnosed in cases with increased serum cholesterol (>180 mg/dL).

    Serum markers of iron overload were defined as increased serum concentration of iron (>28.3 μmol/L) and increased transferrin saturation (>50% in men;>45% in women) and/or increased serum ferritin concentration (>300 ng/mL in men; >200 ng/mL in women). The diagnosis of HH was based on thepresence of biochemical markers of iron overload and detection of homozygous C282YHFEgene mutation.[29]

    Table 1.Selected demographic, laboratory and histologic features in CHC, NAFLD and HH patients

    Interpretation of liver biopsy

    Liver biopsy was performed using the Menghini method[30]in 174/191 CHC and 61/67 NAFLD patients. In 17 CHC and 6 NAFLD patients, liver biopsy was not carried out because of contraindications. The preparation of liver biopsy specimen and the assessment of inflammatory activity and fibrosis were described previously.[28]Pathologist was unaware of the patients' clinical findings. Perls' Prussian blue staining for the detection of iron deposits was performed. Semiquantitative grading was used on a scale of 0-4 for the assessment of iron in hepatocytes.[31]Liver steatosis was graded on a four-grade scale: grade 0: no steatosis, grade I: steatosis in <10% of hepatocytes, grade II: steatosis in 10%-30% of hepatocytes, and grade III: steatosis in more than 30% of hepatocytes. This study was focused on the investigation of the correlation between liver steatosis and iron accumulation. Iron accumulation in hepatocytes, but not in the reticuloendothelial cells, refers to an early phase of iron overload caused by down-regulation of hepcidin. For this reason only deposits found in hepatocytes were scored. Sideronecrosis in liver tissue, with iron accumulation in Kupffer cells, is observed in cases of heavy iron overload, in the advanced phase of HH.[32,33]

    AnalyzingHFEgene polymorphisms

    The genomic DNA from peripheral blood leukocytes was extracted by a High Pure PCR Template Preparation Kit (Roche Diagnostics) according to the manufacturer's instructions. The followingHFEmutations were detected by the PCR-RFLP assay: C282Y, H63D, and S65C.[34]

    Statistical analysis

    Statistical analysis was carried out using data analysis software STATISTICA version 8.0 (StatSoft Inc., USA). All statistical data were presented as a mean ± standard error (SE) or median value (histopathological data). SE was used since the distributions of data were skewed. An analysis of differences between variations was performed using nonparametric statistics: the Mann-WhitneyUtest, the Chi-square test and Spearman's rank-order correlation coefficient test. Relationshipsbetween variables were estimated by multivariate linear and logistic regressions. APvalue of less than 0.05 was considered statistically significant.

    Results

    Characteristics of CHC patients

    The majority of CHC patients were infected with HCV genotype 1, and more than 50% of these patients had a BMI above 25 kg/m2. Diabetes mellitus was diagnosed in 25% and hyperlipidemia in 9% of CHC patients. HCV 3 genotype-infected patients had significantly lower BMIs (r=-0.199;P<0.05). The median value of inflammation activity and fibrosis, in patients subjected to liver biopsy, corresponded to chronic hepatitis of moderate intensity. Eighty-two patients presented elevated serum parameters of iron overload. The mean concentrations of serum iron, ferritin and transferrin saturations exceeded normal values. Hepatocyte steatosis was present in 76 and hepatocyte iron deposits were detected in 74 CHC patients. In most of CHC patients, both steatosis and iron deposition assessed in histopathological examination were mild. Elevated biochemical iron parameters correlated with increased fibrotic severity (P=0.00059) but not with inflammation activity. Mean HCV viral load was (4.344±1.212)×106IU/mL. Load was not associated with liver steatosis or serum and liver iron overload. DifferentHFEgene mutations were detected in 78 CHC patients. Coexistence of CHC with HH was confirmed in 3 patients.

    Differences between patients with and without liver steatosis in the CHC group are presented in Table 2. Univariate analysis confirmed the presence of liver steatosis more frequently in CHC patients with serum markers of iron accumulation than those without (OR=2.076;P=0.02; 95% CI: 1.118-3.856). Multivariate analysis in the CHC group revealed that elevated serum iron parameters were associated only with higher BMI and more frequent occurrence of diabetes mellitus (χ2=19.2;P=0.00007). Moreover, liver steatosis was diagnosed more frequently in patients with arterial hypertension and higher BMIs (χ2=13.6;P=0.001). In the CHC patients with liver steatosis, tissue iron accumulation without biochemical iron disturbances occurred more rarely than in hepatocytes with iron deposits accompanied by elevated serum iron indices (χ2=15.73;P=0.0001).

    Comparison of CHC with NAFLD and HH patients

    Differences between CHC patients and NAFLD or HH patients are presented in Table 1. Gender and BMI distributions were different in the CHC and NAFLD patients, but the mean age was similar. CHC and HH patients were not different in relation to these features (Table 2). The presence of serum and tissue markers of iron overload was similar in CHC and NAFLD patients. Iron overload, confirmed by both serum iron parameters and liver iron deposits, wasmore severe in HH than that in CHC patients. In all patients with genetic hemochromatosis subjected to liver biopsy, hepatocyte iron deposition of very high intensity was confirmed. Among patients with liver steatosis, the higher biochemical activities of liver enzymes related to liver injury and higher serum iron concentrations with higher transferrin saturations were found more frequently in CHC patients than in NAFLD patients (Table 2). NAFLD patients presented stronger associations of BMI and hyperlipidemia with liver steatosis than CHC patients did (Table 2). Higher liver inflammation activities and fibrosis stages were confirmed in CHC patients compared with NAFLD patients, and they were independent of liver steatosis (Table 2).

    Table 2.Selected demographic, laboratory and histologic features in study subjects with hepatocyte steatosis

    In the NAFLD group liver steatosis was not correlated with elevated biochemical iron parameters. However, higher serum ferritin concentration was significantly associated with the presence of hepatocytes steatosis in NAFLD patients (729±76.6 vs 543±101 ng/ mL;P=0.018). No significant relationship was found between hepatocyte iron deposits and liver steatosis. In the CHC and NAFLD groups, elevated biochemical iron parameters correlated with increased fibrotic severity (P=0.00022) but not with increased inflammatory severity. In the CHC group significantly more active liver inflammation and more intense liver fibrosis were observed. In the CHC group, however, multivariate logistic regression modeling showed that only serum markers of iron overload were independent factors associated with liver steatosis (P=0.021; OR=2.18; 95% CI: 1.12-4.22).

    Ferritin was not correlated with inflammation activity, and it was a good predictor of liver iron deposition in the CHC and NAFLD groups (P<0.000001). But its concentration was dependent on the severity of fibrosis (P=0.009 for CHC andP=0.019 for NAFLD patients).

    HFEgene mutations in the CHC and NAFLD groups

    HFEgene mutations were detected in NAFLD at a similar frequency in CHC (31/67, 46%) patients (Table 3). In CHC and NAFLD patients, C282Y mutation was associated with elevated serum iron parameters (allP=0.002) and liver iron accumulation (P=0.0295 andP=0.0002, respectively). OtherHFEgene mutations were detected more frequently in HCV-infected patients with liver iron deposits (P=0.04) but without statistical significance in patients with elevated serum iron parameters (P=0.08). In the NAFLD group, the association ofHFEmutations with elevated biochemical iron parameters and liver iron overload was significant (P=0.024 andP=0.003, respectively). Additionally, inthe NAFLD group, but not the CHC group, H63DHFEpolymorphism was positively correlated with higher serum iron concentrations (P=0.04) and liver iron deposits (P=0.006). No correlation of liver steatosis withHFEpolymorphism was found in CHC or NAFLD patients. HH patients compared with CHC patients presented similar frequency and intensity of hepatocyte steatosis despite more severe serum and liver iron overload.

    Discussion

    Liver accumulation of iron or fat deposits in CHC patients have been reported previously. However, the potential impact of excess iron, induced by HCV infection on steatosis development has not been a frequent subject of studies. Fatty changes in liver biopsy specimens were found in 44% of HCV-infected patients.[35-37]Clinical observations revealed that liver steatosis was dependent on the following: viral factors in HCV genotype 3 or metabolic syndrome in HCV genotype 1 infection.[37-39]We did not find the correlation of liver steatosis with HCV genotype 3 because only few patients who had been infected with this genotype were included in the study. Genotype 1b is dominant in the Polish population. The prevalence of HCV genotype 3 has been increasing since 2000, especially among intravenous drug users.[40,41]In our series, only 3 patients reported intravenous use of drugs, and 81/191 (42%) individuals had been infected before 2000. Moreover the frequency of metabolic syndrome symptoms influenced the above results as patients infected with genotype 1b were more frequently obese. An overrepresentation of males in our study corresponded to results from previous studies on liver disease morbidity.[42]

    Obesity was the strongest factor associated with liver steatosis in all subjects; however, lipid metabolism disorders were associated with steatosis only in NAFLD patients. Most patients with NAFLD had simple liver steatosis explaining the lower ALT and AST activitiesand lower liver inflammation and fibrosis grades in this group. The prevalence of serum markers of iron accumulation was similar in the CHC and NAFLD groups. However, higher serum iron concentration and transferrin saturation in the CHC group compared with NAFLD group reflected different pathogenic mechanisms leading to iron overload. In HCV-infected patients, it was partially due to HCV-induced liver injury and down-regulation of hepcidin.[18,19]

    Our study confirmed the association of ferritin concentration with fibrotic staging, and found that ferritin concentration was a good predictor of liver iron deposition in the study groups. Liver steatosis was associated with higher ferritin concentration in NAFLD patients and could be related to insulin resistance syndrome with iron overload.[43,44]This syndrome, frequently associated with NAFLD, was characterized by hyperferritinemia, normal transferrin saturation and mild to moderate iron overload. In NAFLD patients with insulin resistance syndrome, increased ferritin concentration was an indicator of growing tissue iron deposition; such deposition may be resulted from the insulin induced stimulation of cellular iron uptake and a redistribution of intracellular transferrin receptors to the plasma membrane.[45]In our study, we did not diagnose insulin resistance syndrome. In the CHC group, the type of disturbances of iron homeostasis was different from that described for this syndrome. Hepatocyte steatosis in CHC patients correlated both with higher serum iron concentration and transferrin saturation.

    We confirmed the association between elevated biochemical iron parameters and liver steatosis by univariate regression analysis in CHC patients. However, these parameters did not serve as an independent factor correlated with steatosis in the multivariate analysis, perhaps because of the strong effects of metabolic features (>50% of patients with BMIs above the normal value and, >25% of patients with coexisting diabetes mellitus). The above-mentioned correlation which was found only in CHC patients was intriguing. This correlation indicates an effect of iron overload on steatosis development and corresponds to the results of experiments, suggesting the impact of HCV on hepatic lipogenesis induction in the presence of iron.[27]

    The association of hepatocyte iron deposits with liver steatosis was not shown in this study. In an Italian study of 242 CHC patients, liver iron deposits correlated with liver steatosis grade. The authors confirmed this association in patients infected with HCV genotype 3 and assessed not only the presence of iron in hepatocytes but also the reticuloendothelial iron pattern.[39]In our study we did not analyze the correlation of iron deposits in macrophages with fat accumulation in the liver. We focused on the investigation of the possible influence of serum or liver iron concentrations on the development of liver steatosis. Most of the patients presented with mild or moderate liver iron deposits in their hepatocytes. Heavy iron loading and severe necroinflammatory activity in the liver was observed in a minority of patients. The hepatocyte pattern of iron accumulation is related to hepcidin inhibition, which is proposed to play an essential role in the pathogenesis of most common syndromes of iron overload. Experiments on mice furnished evidence for the down-regulation of hepcidin during HCV infection.[18,19]Controlling plasma iron levels is the main function of hepcidin, the peptide regulator of iron homeostasis. Decreased level of hepcidin results in free, unlimited efflux of iron out of macrophages and enterocytes with increased plasma iron and transferrin saturation. Binding and oxidation of Fe2+within the shell of ferritin protects cells against the toxicity of a labile iron pool (nonprotein-bound iron), and liver alone serves in this protective role as the main storage location for iron in the body. When the physiological capacity of liver iron storage is not sufficient for increasing body iron content (transferrin saturation >75%), it leads to the appearance of toxic non-transferrin bound iron (NTBI), which has a high potential for generating reactive oxygen radicals.[32,46]The activity of highly toxic NTBI is suggested to be mainly responsible for tissue damage due to iron toxicity.[47]Perhaps the impact of iron and HCV cooperation on liver steatosis is dependent more on the presence of toxic NTBI or free iron than the presence of hepatocyte iron deposits in terms of iron's association with moderate increases in serum ferritin.[27]CHC patients with liver steatosis presented significantly more frequently with serum and tissue markers of iron accumulation, not simple hepatocyte iron deposits. This unique model of interaction between disturbed iron homeostasis and liver steatosis in CHC patients can also be confirmed by observing HH patients. In the HH group, no association of severe serum or tissue iron overload with liver steatosis was observed.

    Contrary to observations by Valenti et al,[37]HFEgene mutations may lead to iron disorders in chronic liver diseases, but their prevalence was not correlated with liver steatosis in a population of Polish patients. In CHC patients, a significant association of onlyHFEgene mutations, excluding the C282Y mutation, with the presence of hepatic iron overload indicates that chronic HCV infection itself disrupts most strongly the normal regulation of plasma iron levels. Nevertheless,the interaction between fat accumulation in hepatocytes and iron disorders in CHC patients needs further clinical validation. If a probable synergistic influence in the course of this disease was proved, the issue of iron removal, as an option for CHC treatment, especially in difficult-to-treat HCV-infected patients, would require reconsideration.

    In conclusion, in this series liver steatosis was diagnosed in nearly half of patients with CHC, most of whom were infected with genotype 1. The intensity of steatosis was lower in CHC patients compared with NAFLD patients possibly because of a less frequent diagnosis of metabolic syndrome. In the CHC group only biochemical markers of iron accumulation positively were correlated with liver steatosis. In CHC and NAFLD patients, the presence ofHFEgene mutations was not associated with liver steatosis. Therefore we postulate that in CHC patients virusinduced disruption of iron homeostasis may act as a cofactor for liver steatosis.

    Contributors:SK proposed the study. SK and SP collected and analyzed the data, and prepared the manuscript. RT performed genetic tests. RR performed histopathological examinations of liver biopsy specimens. BKP coordinated the research team and reviewed the manuscript.

    Funding:The study was supported by a grant from Medical University of Gdansk (W-175).

    Ethical approval:The study protocol was approved by the Local Ethics Committee (NKEB 270/2010).

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, Wedemeyer H, et al. Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat 2009;16:75-90.

    2 Halfon P, Locarnini S. Hepatitis C virus resistance to protease inhibitors. J Hepatol 2011;55:192-206.

    3 Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003;97:3036-3043.

    4 Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, et al. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int 2007;27:1394-1401.

    5 Isom HC, McDevitt EI, Moon MS. Elevated hepatic iron: a confounding factor in chronic hepatitis C. Biochim Biophys Acta 2009;1790:650-662.

    6 Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 2003;98:2064-2071.

    7 Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, et al. Critical role of PA28gamma in hepatitis C virusassociated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A 2007;104:1661-1666.

    8 Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002;16:185-194.

    9 Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33:1358-1364.

    10 Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527-1531.

    11 Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 2004;53:406-412.

    12 Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592-599.

    13 Harrison SA. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. Clin Gastroenterol Hepatol 2008;6:864-876.

    14 Machado MV, Cortez-Pinto H. Insulin resistance and steatosis in chronic hepatitis C. Ann Hepatol 2009;8:S67-75.

    15 Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004;165:1499-1508.

    16 Persico M, Capasso M, Persico E, Svelto M, Russo R, Spano D, et al. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy. Hepatology 2007;46:1009-1015.

    17 Pazienza V, Clément S, Pugnale P, Conzelman S, Foti M, Mangia A, et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 2007; 45:1164-1171.

    18 Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008;48:1420-1429.

    19 Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008;134:226-238.

    20 Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: relationship withHFEmutations. Gastroenterology 2003;124: 318-326.

    21 Sikorska K, Stalke P, Izycka-Swieszewska E, Romanowski T, Bielawski KP. The role of iron overload andHFEgene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C. Med Sci Monit 2010;16:CR137-143.

    22 Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996;16:13-30.

    23 Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 2002;37:527-535.

    24 Hübscher SG. Iron overload, inflammation and fibrosis in genetic haemochromatosis. J Hepatol 2003;38:521-525.

    25 Bassett ML. Iron and hepatitis C: beginning to make sense. J Gastroenterol Hepatol 2007;22:1703-1704.

    26 Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, et al. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol 2004;39:570-574.

    27 Nishina S, Korenaga M, Hidaka I, Shinozaki A, Sakai A, Gondo T, et al. Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice. Liver Int 2010;30:683-692.

    28 Sikorska K, Bielawski KP, Stalke P, Lakomy EA, Michalska Z, Witczak-Malinowska K, et al.HFEgene mutations in Polish patients with disturbances of iron metabolism: an initial assessment. Int J Mol Med 2005;16:1151-1156.

    29 European Association For The Study Of The Liver. EASL clinical practice guidelines forHFEhemochromatosis. J Hepatol 2010;53:3-22.

    30 Menghini G. The needle biopsy of the liver, an effective technical progress. Sci Med Ital 1957;6:212-229.

    31 LeSage GD, Baldus WP, Fairbanks VF, Baggenstoss AH, McCall JT, Moore SB, et al. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983;84:1471-1477.

    32 Crichton R. Iron metabolism--from molecular mechanisms to clinical consequences. Chichester: Wiley;2009.

    33 Deugnier YM, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102: 2050-2059.

    34 Sikorska K, Stalke P, Jaskiewicz K, Romanowski T, Bielawski KP. Could iron deposits in hepatocytes serve as a prognostic marker ofHFEgene mutations? Hepatogastroenterology 2008;55:1024-1028.

    35 Clouston AD, Powell EE. Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol 2002;16:767-781.

    36 Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004;126:586-597.

    37 Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, et al. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 2007;92:1037-1042.

    38 Koike K, Moriya K. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH. J Gastroenterol 2005;40:329-336.

    39 Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J Viral Hepat 2006;13:199-205.

    40 Brojer E, Grabarczyk P, Kopacz A, Potepa A, Medyńska J, Smolarczyk-Wodzyńska J, et al. HCV genotypes in Polish blood donors in period 1995-2007. Przegl Epidemiol 2008;62: 163-169.

    41 Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, et al. Changing HCV genotypes distribution in Poland--relation to source and time of infection. J Clin Virol 2008;42:156-159.

    42 Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-967.

    43 Moirand R, Mortaji AM, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-97.

    44 Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999;117:1155-1163.

    45 Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986;261:8708-8711.

    46 Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.

    47 Brissot P, Loréal O. Role of non-transferrin-bound iron in the pathogenesis of iron overload and toxicity. Adv Exp Med Biol 2002;509:45-53.

    April 3, 2012

    Accepted after revision December 25, 2012

    Author Affiliations: Department of Infectious Diseases, Medical University of Gdansk, Smoluchowskiego 18, 80-214 Gdansk, Poland (Sikorska K and Stalke P); Department of Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Kladki 24, 80-822 Gdansk, Poland (Romanowski T and Bielawski KP); Department of Pathology, Medical University of Gdansk, Debinki 7, 80-952 Gdansk, Poland (Rzepko R)

    Krzysztof Piotr Bielawski, Department of Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Kladki 24, 80-822 Gdansk, Poland (Tel: 48-58-3412887; Email: bielawski@biotech.ug.gda.pl)

    ? 2013, Hepatobiliary Pancreat Dis Int. All rights reserved.

    10.1016/S1499-3872(13)60059-4

    色哟哟哟哟哟哟| 国产一区二区在线观看日韩| 最近在线观看免费完整版| 成人永久免费在线观看视频| 欧美日韩综合久久久久久| 99久久久亚洲精品蜜臀av| 亚洲乱码一区二区免费版| 天堂动漫精品| 国产亚洲精品久久久com| 国产精品久久久久久久久免| 欧美日本视频| 一区二区三区高清视频在线| АⅤ资源中文在线天堂| 嫩草影院入口| 丰满乱子伦码专区| 亚洲第一区二区三区不卡| 免费av毛片视频| 99国产极品粉嫩在线观看| 国语自产精品视频在线第100页| 内射极品少妇av片p| 啦啦啦啦在线视频资源| 日日摸夜夜添夜夜爱| 婷婷色综合大香蕉| 99视频精品全部免费 在线| 欧美最黄视频在线播放免费| 亚洲第一电影网av| 成熟少妇高潮喷水视频| 国产麻豆成人av免费视频| 亚洲av免费高清在线观看| 久久久久国内视频| 成人午夜高清在线视频| 激情 狠狠 欧美| 亚州av有码| 欧美成人a在线观看| 久久草成人影院| 亚洲成av人片在线播放无| 日本-黄色视频高清免费观看| 午夜a级毛片| 欧美日韩乱码在线| 国产v大片淫在线免费观看| 日韩欧美在线乱码| 欧美人与善性xxx| 99国产精品一区二区蜜桃av| av专区在线播放| 午夜福利视频1000在线观看| 亚洲高清免费不卡视频| 成人漫画全彩无遮挡| 蜜桃久久精品国产亚洲av| 我要搜黄色片| 女同久久另类99精品国产91| 黄色欧美视频在线观看| 级片在线观看| 成熟少妇高潮喷水视频| 欧美中文日本在线观看视频| 午夜激情福利司机影院| 狂野欧美白嫩少妇大欣赏| 国产精品美女特级片免费视频播放器| 99久国产av精品国产电影| 最后的刺客免费高清国语| 一边摸一边抽搐一进一小说| 久久久久久久久久久丰满| 久久鲁丝午夜福利片| 99国产极品粉嫩在线观看| 成人特级av手机在线观看| 最近在线观看免费完整版| 99热这里只有是精品50| ponron亚洲| 天堂动漫精品| 乱系列少妇在线播放| 欧美一级a爱片免费观看看| 网址你懂的国产日韩在线| av国产免费在线观看| 久久久精品欧美日韩精品| 乱系列少妇在线播放| 成人综合一区亚洲| 日韩一本色道免费dvd| 国产黄a三级三级三级人| 老司机影院成人| 午夜精品一区二区三区免费看| 人人妻人人澡人人爽人人夜夜 | 一进一出好大好爽视频| 国产精品久久久久久av不卡| 99riav亚洲国产免费| 国产高清不卡午夜福利| 男人和女人高潮做爰伦理| 最近视频中文字幕2019在线8| 日本爱情动作片www.在线观看 | 中文字幕人妻熟人妻熟丝袜美| 中文在线观看免费www的网站| 国内精品久久久久精免费| 给我免费播放毛片高清在线观看| 久久久久久久久久黄片| 两性午夜刺激爽爽歪歪视频在线观看| av专区在线播放| 久久亚洲国产成人精品v| 夜夜看夜夜爽夜夜摸| av中文乱码字幕在线| 亚洲精品成人久久久久久| 国产男人的电影天堂91| 高清日韩中文字幕在线| 此物有八面人人有两片| 亚洲av中文字字幕乱码综合| 国产成人影院久久av| 成年女人永久免费观看视频| 亚洲最大成人av| 久久天躁狠狠躁夜夜2o2o| 一进一出抽搐动态| 久久99热这里只有精品18| 日韩在线高清观看一区二区三区| 97热精品久久久久久| 91久久精品电影网| 亚洲人成网站在线播| 91久久精品国产一区二区三区| 国产黄片美女视频| 中文字幕精品亚洲无线码一区| 草草在线视频免费看| 少妇的逼水好多| 午夜老司机福利剧场| 国产男靠女视频免费网站| 丝袜喷水一区| 日日摸夜夜添夜夜爱| 久久久午夜欧美精品| 亚洲人成网站高清观看| 男女之事视频高清在线观看| 精品一区二区三区人妻视频| 亚洲av不卡在线观看| 欧美性猛交黑人性爽| 亚洲av二区三区四区| 99热6这里只有精品| 久久精品国产清高在天天线| 91在线观看av| 男人的好看免费观看在线视频| 欧美日本亚洲视频在线播放| av黄色大香蕉| 久久综合国产亚洲精品| 国产精品一区二区性色av| 欧美成人免费av一区二区三区| 国产黄a三级三级三级人| 波野结衣二区三区在线| 国产麻豆成人av免费视频| 久久久久久久久大av| 欧美人与善性xxx| 能在线免费观看的黄片| www日本黄色视频网| 一级毛片aaaaaa免费看小| 成人午夜高清在线视频| 亚洲精品亚洲一区二区| 一本精品99久久精品77| 美女xxoo啪啪120秒动态图| 精品久久久久久久人妻蜜臀av| 波多野结衣高清作品| 国产麻豆成人av免费视频| 国产精品福利在线免费观看| 国产色婷婷99| 午夜福利视频1000在线观看| 美女黄网站色视频| 黄色日韩在线| 国产av一区在线观看免费| 天美传媒精品一区二区| 亚洲成人久久性| av专区在线播放| 波多野结衣高清无吗| 国产精品野战在线观看| 国产欧美日韩一区二区精品| 国产一区亚洲一区在线观看| 精品熟女少妇av免费看| 亚洲在线观看片| 精品欧美国产一区二区三| 国产精品一区二区三区四区久久| 亚洲成人av在线免费| 天堂网av新在线| 午夜精品国产一区二区电影 | 亚洲成人中文字幕在线播放| 免费看光身美女| 成年av动漫网址| 亚洲精品影视一区二区三区av| 男女做爰动态图高潮gif福利片| 国产黄片美女视频| 乱码一卡2卡4卡精品| 国内精品宾馆在线| 有码 亚洲区| 日本五十路高清| 亚洲欧美日韩东京热| 亚洲不卡免费看| 日韩欧美精品免费久久| 国产高清视频在线观看网站| 少妇丰满av| 狠狠狠狠99中文字幕| 免费人成视频x8x8入口观看| av视频在线观看入口| 卡戴珊不雅视频在线播放| 一区二区三区免费毛片| 久久九九热精品免费| 亚洲精品影视一区二区三区av| 在线免费观看的www视频| ponron亚洲| 亚洲欧美日韩东京热| 中文在线观看免费www的网站| 亚洲欧美中文字幕日韩二区| 亚洲最大成人av| 色噜噜av男人的天堂激情| av.在线天堂| 中文字幕av在线有码专区| 蜜桃亚洲精品一区二区三区| 午夜福利在线观看吧| 干丝袜人妻中文字幕| 亚洲av成人精品一区久久| 午夜视频国产福利| 中国美白少妇内射xxxbb| 亚洲欧美日韩东京热| 精品不卡国产一区二区三区| 国产一级毛片七仙女欲春2| 男人舔女人下体高潮全视频| 三级国产精品欧美在线观看| 亚洲性久久影院| 十八禁国产超污无遮挡网站| 97超级碰碰碰精品色视频在线观看| 欧美在线一区亚洲| 亚洲av成人av| 婷婷色综合大香蕉| 亚洲欧美精品自产自拍| 国产午夜精品论理片| 又粗又爽又猛毛片免费看| 日本与韩国留学比较| 国产大屁股一区二区在线视频| 婷婷亚洲欧美| 日韩欧美一区二区三区在线观看| 搡老妇女老女人老熟妇| 中文字幕精品亚洲无线码一区| 波多野结衣巨乳人妻| 成年版毛片免费区| 亚洲欧美日韩卡通动漫| 亚洲国产欧洲综合997久久,| av天堂在线播放| 九九在线视频观看精品| 国产精品人妻久久久久久| 日本三级黄在线观看| 非洲黑人性xxxx精品又粗又长| 18禁在线无遮挡免费观看视频 | 精品一区二区三区视频在线| а√天堂www在线а√下载| 亚洲熟妇熟女久久| 男女下面进入的视频免费午夜| 老熟妇仑乱视频hdxx| 亚洲经典国产精华液单| 人人妻人人看人人澡| 国产久久久一区二区三区| 麻豆国产av国片精品| 欧美激情在线99| 97在线视频观看| 国产蜜桃级精品一区二区三区| 欧美一区二区精品小视频在线| 婷婷亚洲欧美| 18+在线观看网站| 十八禁国产超污无遮挡网站| 国产精品伦人一区二区| 简卡轻食公司| 男女视频在线观看网站免费| 噜噜噜噜噜久久久久久91| 日日撸夜夜添| 欧美日韩在线观看h| 麻豆久久精品国产亚洲av| 黄色一级大片看看| 在线国产一区二区在线| 老女人水多毛片| 亚洲久久久久久中文字幕| 久久人人爽人人片av| 久久久色成人| 久久天躁狠狠躁夜夜2o2o| 天美传媒精品一区二区| 色综合站精品国产| 亚洲自偷自拍三级| 婷婷六月久久综合丁香| 少妇人妻一区二区三区视频| 22中文网久久字幕| 国产精品久久久久久久电影| 黄色一级大片看看| 国产伦在线观看视频一区| 看片在线看免费视频| 亚洲av成人精品一区久久| 久久精品国产亚洲av天美| 最近2019中文字幕mv第一页| 亚洲av免费高清在线观看| 国产精品久久视频播放| 岛国在线免费视频观看| 国产精品精品国产色婷婷| 国产欧美日韩精品亚洲av| 久久婷婷人人爽人人干人人爱| 深夜a级毛片| 日韩国内少妇激情av| 国产综合懂色| 中国美女看黄片| 日日干狠狠操夜夜爽| 激情 狠狠 欧美| 男女边吃奶边做爰视频| 亚洲熟妇中文字幕五十中出| 日韩欧美一区二区三区在线观看| 美女免费视频网站| 国产一区二区三区av在线 | 尾随美女入室| 小蜜桃在线观看免费完整版高清| 啦啦啦韩国在线观看视频| 又黄又爽又刺激的免费视频.| 久久精品国产亚洲av天美| 中文字幕免费在线视频6| 久久精品国产99精品国产亚洲性色| 非洲黑人性xxxx精品又粗又长| 简卡轻食公司| 午夜爱爱视频在线播放| 麻豆国产av国片精品| 老司机影院成人| 久久久国产成人免费| 国产淫片久久久久久久久| 久久九九热精品免费| 99久国产av精品国产电影| 午夜福利视频1000在线观看| 午夜老司机福利剧场| 欧美zozozo另类| 两个人视频免费观看高清| 亚洲av熟女| 一个人观看的视频www高清免费观看| 亚洲av电影不卡..在线观看| 欧美不卡视频在线免费观看| 婷婷精品国产亚洲av在线| 91麻豆精品激情在线观看国产| 日本爱情动作片www.在线观看 | 99久久久亚洲精品蜜臀av| 久久中文看片网| 亚洲av美国av| 久久久久久久午夜电影| 国产一区二区三区在线臀色熟女| 久久综合国产亚洲精品| 亚洲av熟女| 亚洲精品久久国产高清桃花| 一边摸一边抽搐一进一小说| 国产亚洲av嫩草精品影院| 国产真实乱freesex| 国产美女午夜福利| 成年免费大片在线观看| 国产v大片淫在线免费观看| 可以在线观看的亚洲视频| 日韩av在线大香蕉| 日韩 亚洲 欧美在线| 美女高潮的动态| 中文字幕av在线有码专区| 亚洲精品一区av在线观看| 国产精品免费一区二区三区在线| 欧美激情在线99| 老司机福利观看| 欧美激情久久久久久爽电影| 91av网一区二区| 日日撸夜夜添| 色综合站精品国产| а√天堂www在线а√下载| 国模一区二区三区四区视频| 久久九九热精品免费| 久久久久性生活片| 免费黄网站久久成人精品| 亚洲在线自拍视频| 亚洲人成网站在线观看播放| 一个人看视频在线观看www免费| 欧美最新免费一区二区三区| 身体一侧抽搐| 色在线成人网| 亚洲av.av天堂| 久久久久久国产a免费观看| 我要搜黄色片| 99riav亚洲国产免费| 国产真实乱freesex| 欧美中文日本在线观看视频| 亚洲不卡免费看| 国产精品电影一区二区三区| 欧美+日韩+精品| 国产精品亚洲一级av第二区| 国产女主播在线喷水免费视频网站 | 国产午夜精品久久久久久一区二区三区 | 特级一级黄色大片| 亚洲成人av在线免费| 嫩草影视91久久| 在线观看一区二区三区| 亚洲国产欧洲综合997久久,| av在线天堂中文字幕| 成人无遮挡网站| 少妇熟女欧美另类| 免费黄网站久久成人精品| 国产精品电影一区二区三区| 天天一区二区日本电影三级| 国产午夜福利久久久久久| 神马国产精品三级电影在线观看| 日本 av在线| 国产精品日韩av在线免费观看| 丝袜美腿在线中文| 国产欧美日韩一区二区精品| 蜜桃亚洲精品一区二区三区| 99热这里只有是精品50| 国产伦一二天堂av在线观看| 亚洲中文字幕日韩| 国产真实伦视频高清在线观看| 在线免费观看的www视频| 免费大片18禁| 日本一二三区视频观看| 国产日本99.免费观看| 国产乱人偷精品视频| 在线国产一区二区在线| 国产视频一区二区在线看| 99国产极品粉嫩在线观看| 国产私拍福利视频在线观看| 免费看美女性在线毛片视频| 国产精华一区二区三区| 国产单亲对白刺激| 国产精品电影一区二区三区| 亚洲av五月六月丁香网| 97碰自拍视频| av免费在线看不卡| 超碰av人人做人人爽久久| 最近在线观看免费完整版| 色av中文字幕| 99久久精品一区二区三区| 一个人看的www免费观看视频| 97碰自拍视频| 国产成年人精品一区二区| 亚洲欧美日韩卡通动漫| 午夜激情福利司机影院| 丝袜喷水一区| 99久久九九国产精品国产免费| 久久久久久九九精品二区国产| 一区福利在线观看| 99九九线精品视频在线观看视频| 99久久精品国产国产毛片| 精品99又大又爽又粗少妇毛片| 久久久欧美国产精品| 身体一侧抽搐| 俺也久久电影网| 伦精品一区二区三区| 91久久精品国产一区二区三区| 男人狂女人下面高潮的视频| 成年免费大片在线观看| 老师上课跳d突然被开到最大视频| 蜜桃亚洲精品一区二区三区| 赤兔流量卡办理| 成人特级黄色片久久久久久久| 一a级毛片在线观看| 最近视频中文字幕2019在线8| 久久精品国产清高在天天线| 久久久久免费精品人妻一区二区| 你懂的网址亚洲精品在线观看 | 久久韩国三级中文字幕| 啦啦啦啦在线视频资源| 看片在线看免费视频| 国产一级毛片七仙女欲春2| 香蕉av资源在线| 天天躁日日操中文字幕| 亚洲欧美精品综合久久99| 亚洲无线观看免费| 天天躁夜夜躁狠狠久久av| 国产男人的电影天堂91| 俺也久久电影网| 国产av一区在线观看免费| 伦理电影大哥的女人| 成人三级黄色视频| 超碰av人人做人人爽久久| 久久久a久久爽久久v久久| 欧美日韩精品成人综合77777| 国产亚洲av嫩草精品影院| 久久亚洲国产成人精品v| 一进一出好大好爽视频| 最近2019中文字幕mv第一页| 少妇熟女aⅴ在线视频| 十八禁网站免费在线| 精品久久久久久成人av| 三级经典国产精品| 久久久成人免费电影| 最后的刺客免费高清国语| 午夜久久久久精精品| 国产精品久久久久久久电影| 精品乱码久久久久久99久播| 男插女下体视频免费在线播放| 国产 一区 欧美 日韩| 亚洲电影在线观看av| 精品午夜福利在线看| 精品一区二区三区视频在线| 联通29元200g的流量卡| ponron亚洲| 国产一区二区三区在线臀色熟女| 久久久久性生活片| 欧美人与善性xxx| www日本黄色视频网| 少妇猛男粗大的猛烈进出视频 | 男插女下体视频免费在线播放| 久久久欧美国产精品| 丰满的人妻完整版| 狂野欧美白嫩少妇大欣赏| av天堂中文字幕网| 久久综合国产亚洲精品| 黄色欧美视频在线观看| 久久精品国产亚洲av香蕉五月| 一级毛片我不卡| 一级毛片aaaaaa免费看小| 亚洲av中文av极速乱| 午夜亚洲福利在线播放| 夜夜夜夜夜久久久久| 免费看光身美女| 免费av毛片视频| 国产精品嫩草影院av在线观看| a级一级毛片免费在线观看| 日本与韩国留学比较| 日日干狠狠操夜夜爽| av黄色大香蕉| 两个人的视频大全免费| 嫩草影院精品99| 日本黄色片子视频| 老熟妇乱子伦视频在线观看| 在线免费观看的www视频| 成人av在线播放网站| 日韩成人伦理影院| 搡老岳熟女国产| 性色avwww在线观看| 99久久精品一区二区三区| 亚洲成人精品中文字幕电影| 亚洲av熟女| 亚洲人成网站高清观看| 男人舔奶头视频| 亚洲av熟女| 国产在线精品亚洲第一网站| 国内少妇人妻偷人精品xxx网站| 欧美性猛交╳xxx乱大交人| 免费看日本二区| 亚洲中文字幕日韩| 狂野欧美激情性xxxx在线观看| 特大巨黑吊av在线直播| 高清午夜精品一区二区三区 | 欧美日韩精品成人综合77777| 午夜老司机福利剧场| av专区在线播放| 3wmmmm亚洲av在线观看| 日本欧美国产在线视频| 国产午夜精品论理片| 亚洲av.av天堂| 少妇熟女欧美另类| 亚洲精品一卡2卡三卡4卡5卡| 久久精品影院6| 久久精品国产99精品国产亚洲性色| 欧美日韩综合久久久久久| 综合色av麻豆| 久久久久精品国产欧美久久久| 男女啪啪激烈高潮av片| 成人午夜高清在线视频| 亚洲三级黄色毛片| 日韩欧美精品v在线| 亚洲四区av| 久久久久久久久久成人| 亚洲av美国av| 中出人妻视频一区二区| 日本黄大片高清| 天美传媒精品一区二区| 午夜精品一区二区三区免费看| 欧美日本亚洲视频在线播放| 久久久久九九精品影院| 国产精品99久久久久久久久| 色吧在线观看| 成人鲁丝片一二三区免费| 一级黄色大片毛片| 成人漫画全彩无遮挡| 老女人水多毛片| 91av网一区二区| 好男人在线观看高清免费视频| 国产精品乱码一区二三区的特点| 久久久久久久久久黄片| 国产v大片淫在线免费观看| 悠悠久久av| 亚洲精品影视一区二区三区av| 日韩欧美在线乱码| 美女黄网站色视频| 欧美成人精品欧美一级黄| 中文字幕av成人在线电影| 亚洲高清免费不卡视频| 日韩成人伦理影院| 国产男人的电影天堂91| 亚洲久久久久久中文字幕| 欧美又色又爽又黄视频| 免费观看的影片在线观看| 少妇熟女aⅴ在线视频| 亚洲无线在线观看| 国产精品一区二区免费欧美| 3wmmmm亚洲av在线观看| 精品无人区乱码1区二区| 亚洲第一区二区三区不卡| 你懂的网址亚洲精品在线观看 | 女人被狂操c到高潮| 国产爱豆传媒在线观看| 俺也久久电影网| 色综合色国产| 一级毛片久久久久久久久女| 国产欧美日韩精品一区二区| 日韩欧美一区二区三区在线观看| 久久草成人影院| 神马国产精品三级电影在线观看| 久久九九热精品免费| av福利片在线观看| 两个人视频免费观看高清| 久久亚洲国产成人精品v| 有码 亚洲区| 天堂网av新在线| 香蕉av资源在线| 亚洲国产精品久久男人天堂| 一级a爱片免费观看的视频| 欧美色欧美亚洲另类二区| 午夜福利高清视频| 国产精品嫩草影院av在线观看| 日本成人三级电影网站| 春色校园在线视频观看| 此物有八面人人有两片| 国产真实乱freesex| 寂寞人妻少妇视频99o| 日韩高清综合在线|